Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,622 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06102928Recruiting
Anlotinib plus Aumolertinib for first-line treatment of advanced EGFR-mutant lung cancer
This trial tests a combination of two targeted drugs (anlotinib and aumolertinib) as the first treatment for advanced lung cancer with a specific EGFR mutation (L858R). The goal is to see if the combination works better than standard care.
Kunming, YunnanAges 18 years+ - NCT05162677Recruiting
Study skin thickness and tissue after preventive breast removal
This study looks at what happens to the skin and remaining breast tissue after a preventive (non-cancer) mastectomy. It uses imaging and exams to understand why some patients may have skin healing problems.
UmeåAges 18–74 - NCT06102044RecruitingPhase 3
Zinc for young infants with severe infection in Tanzania
This study tests whether giving zinc supplements to very young babies (under 2 months) with severe infections helps them recover better. It takes place in Tanzania and involves adding zinc to their regular care.
Dar es SalaamAges birth–2 months - NCT07679594Recruiting
A study of Luna breast implants for augmentation or reconstruction
This study is testing Eurosilicone Luna breast implants in women who need breast augmentation (enlargement) or reconstruction after mastectomy. It aims to see how safe and effective the implants are over time.
Villefranche-sur-SaôneAges 18–65 - NCT07593027RecruitingPhase 1/Phase 2
Study of IMC-003 for pulmonary arterial hypertension
This trial tests a new drug called IMC-003 for people with pulmonary arterial hypertension (PAH). It aims to see if the drug can help improve symptoms and exercise ability when added to your current PAH medications.
Beijing, Beijing MunicipalityAges 18–75 - NCT06470750Recruiting
Home care for prostate cancer in Black men
This study looks at whether giving some prostate cancer care at home can help Black men and other patients who have trouble getting to the clinic. It tests if home-based care for treatments like hormone therapy, oral pills, or chemotherapy is practical and helps reduce health care gaps.
Jacksonville, FloridaAges 18 years+ - NCT04278469Recruiting
Study for early breast cancer patients with low-risk genes
This trial studies early, hormone receptor–positive, HER2-negative breast cancer and looks at a group with “high clinical risk” but “low genetic (tumor) risk.” It may help researchers understand which patients may benefit most from treatment decisions guided by genetic tumor testing.
SeoulAges 19–80 - NCT06802952Recruiting
Personalized magnetic brain stimulation for early psychosis risk
This study tests whether a type of magnetic brain stimulation (rTMS) can help people who are at high risk for psychosis. The stimulation is personalized using a brain scan called magnetoencephalography (MEG) to target the right areas.
ShanghaiAges 13–35 - NCT06491862Recruiting
Lung cancer care after chemo in Brazil
This study looks at how doctors in Brazil treat non-squamous non-small cell lung cancer after platinum chemotherapy stops working. It aims to understand real-world outcomes and help improve future care.
Belo Horizonte, Minas GeraisAges 18 years+ - NCT06889753RecruitingPhase 2
Pollen extract for menopause symptoms in healthy women
This study tests if a natural pollen extract can help reduce common menopause symptoms like hot flashes, night sweats, and sleep or mood issues. It is for healthy women who are postmenopausal and experiencing at least moderate symptoms.
London, OntarioAges 45–65 - NCT04332692Recruiting
Check if a lung ultrasound helps evaluate discharge after heart failure
This study looks at whether doing lung ultrasounds can better assess people right before they leave the hospital after an acute heart failure flare. It may help doctors decide when someone is ready for discharge and tailor care to reduce risk after leaving.
Vandœuvre-lès-NancyAges 18 years+ - NCT07322211Recruiting
Testing a new daily disposable contact lens
This trial tests a new daily disposable silicone hydrogel contact lens for people with moderate nearsightedness. It will check if the lens is safe, comfortable, and gives good vision.
Kaohsiung CityAges 3 weeks+ - NCT07022288Recruiting
Study of La Roche-Posay cream for mild facial eczema
This study tests whether a specific soothing moisturizer (La Roche-Posay B5 cream) helps people with mild, stable facial eczema. It is a simple, low-risk trial using a cream you can apply at home.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT07448194RecruitingPhase 1
Safety study of HW241045 in healthy adults
This trial tests the safety of a new drug called HW241045 in healthy volunteers. It helps doctors understand how the drug affects the body and if it causes any side effects.
BeijingAges 18–55 - NCT07637877RecruitingPhase 2
New Treatments for HIV Patients With Low Immune Cell Counts
This study tests targeted therapies to help HIV patients whose immune systems haven't fully recovered despite years of successful HIV medication. You may qualify if your CD4 count (a measure of immune health) stays low even though your viral load is undetectable.
Beijing, Beijing MunicipalityAges 18–60 - NCT07330609Recruiting
Gum and bone graft study for dental implants
This trial tests whether using a small piece of tissue from your own body can improve the gum around dental implants. It might help if you have thin or narrow gum tissue.
Kütahya, MerkezAges 1.5 years+ - NCT07545902Recruiting
Urea-based creams for plaque and palm-sole psoriasis
This study tests two medicated creams containing urea (a natural moisturizing ingredient) to treat psoriasis on the skin and on the palms and soles of the feet. The creams may help reduce flaking, scaling, and irritation in people with mild psoriasis.
Chieti, ItaliaAges 18–65 - NCT07717372Recruiting
CRP test for adults with respiratory infection in primary care
This trial tests whether a simple finger-prick test (C-reactive protein or CRP) can help doctors decide whether antibiotics are needed for adults with a cold or other respiratory infection. If you are an adult with recent symptoms and have not taken antibiotics yet, you may be able to join.
JakartaAges 18 years+ - NCT06101082RecruitingPhase 1
Testing anti-HER2-CAR-T cells for advanced solid tumors
This study tests a new type of cell therapy called anti-HER2-CAR-T for people with advanced HER2-positive solid tumors (like breast, stomach, or colon cancer) whose cancer has not responded to other treatments. The therapy uses your own immune cells engineered to target and kill cancer cells.
Shenyang, LiaoningAges 18–70 - NCT06348797RecruitingPhase 1
CAR-T Cells Targeting PD-L1 and DLL3 for Small Cell Lung Cancer
This trial tests a new CAR-T cell therapy that targets two proteins (PD-L1 and DLL3) on small cell lung cancer cells. It's for people whose cancer came back or got worse after standard chemotherapy, and it aims to see if the treatment is safe and works.
Chengdu, SichuanAges 18–70 - NCT06099717Recruiting
Testing a two-tooth dental bridge on one implant
This study tests if a special bridge supported by a single implant can replace three missing back teeth. It may help people who have a large enough jawbone and good overall health.
Goiânia, GoiásAges 18 years+ - NCT06095310Recruiting
Understanding severe depression in hospitalized patients
This study looks at the clinical and psychiatric features of severe depression in adults who are hospitalized. It aims to better understand the condition and improve care.
LilleAges 18 years+ - NCT07683949Enrolling by invitationPhase 1/Phase 2
Capecitabine plus lenvatinib for advanced colorectal cancer
This trial tests a combination of two oral drugs, capecitabine and lenvatinib, in people with advanced colorectal cancer that has stopped responding to three common chemotherapy drugs. It aims to see if this new combination can help shrink tumors or slow cancer growth.
Seongnam-si, Out of USAges 19–99 - NCT07617428Enrolling by invitation
Testing a new blood loss monitor during surgery
This study tests a new system designed to accurately measure blood loss during elective surgery. If you're having planned urological or general surgery, this trial may help doctors better monitor your blood during the procedure.
Lanzhou, GansuAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,622 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.